Sudeep Pharma
Sudeep Pharma Limited is a publicly listed Indian manufacturer of mineral-based pharmaceutical excipients and specialty mineral actives (calcium, iron, magnesium, zinc salts in multiple chelate forms), serving 1,100+ pharmaceutical, food, nutraceutical, and infant nutrition customers across 100+ countries from six global facilities.
- Company typePublic
- Founded1989
- HeadquartersVadodara, India
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sudeep Pharma does
Sudeep Pharma Limited, founded in 1989 in Vadodara, India, is a publicly listed (NSE/BSE: SUDEEPHARM, IPO November 2025) global manufacturer of mineral-based pharmaceutical excipients and specialty mineral actives serving the pharmaceutical, food, and nutrition industries. Its core technology platform centers on high-purity mineral salt production across calcium salts (calcium phosphate, calcium carbonate), iron salts (including ferric pyrophosphate), and magnesium, zinc, potassium, and sodium variants in multiple chemical forms (phosphates, citrates, glycinates, gluconates, carbonates) with proprietary processes in amino-acid chelation and microencapsulation. The company operates six manufacturing facilities globally and serves over 1,100 customers in 100+ countries, with wholly-owned subsidiaries in the USA, Netherlands, and Ireland, and a portfolio of regulatory certifications including US FDA, GMP, FSSC 22000, Excipact, and Halal enabling access to the most regulated excipient markets.
Sudeep Pharma generates revenue through direct B2B sales of its mineral ingredients under multi-year contracts with negotiated, quote-based pricing tied to specifications and volume; FY March 2026 revenue was Rs 642.26 crore with Rs 172.89 crore net profit, both growing above 24% year-over-year. The customer base spans pharmaceutical manufacturers (excipients for tablets and capsules), food and beverage companies (fortification and functional ingredients), nutraceutical and dietary supplement producers (bioavailable mineral forms like glycinates), and now, post the May 2025 NSS acquisition, infant formula and clinical nutrition buyers in Europe. The company's go-to-market combines direct enterprise sales with regional sales offices in India, the USA, and Europe, supported by an online product catalog and technical support staff.
The business is undergoing a strategic diversification from its core pharmaceutical excipient base into adjacent verticals: Sudeep Advanced Materials (SAM), launched in 2024, is developing green precursor cathode active materials and battery-grade iron phosphate for EVs and energy storage, backed by a Rs 600 crore investment in a 100,000 MT facility at Dahej, Gujarat. The promoter family (Sujit Bhayani) retains approximately 68% ownership post-IPO, and the company reports an ROCE of 36%, materially above the 15% industry median, indicating capital-efficient execution of its expansion strategy.
Sudeep Pharma firmographics
Firmographics- Name
- Sudeep Pharma
- Legal name
- Sudeep Pharma Limited
- Website
- https://sudeeppharma.com
- Company type
- Public
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Sudeep Pharma Limited is a publicly listed Indian manufacturer of mineral-based pharmaceutical excipients and specialty mineral actives (calcium, iron, magnesium, zinc salts in multiple chelate forms), serving 1,100+ pharmaceutical, food, nutraceutical, and infant nutrition customers across 100+ countries from six global facilities.
- Ownership category
- akta.pro rank
Sudeep Pharma industry classification
Industry- Product category
- Pharmaceutical Excipients & Mineral Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes) (CRADAOAM)
- akta.pro secondary industries
- Phosphoric Acid & Phosphates (Food-Grade Phosphate Salts) (AFAJAGAD), Gluconic Acid & Gluconates (GDL, Calcium Gluconate) (AFAJAGAH), Vitamins & Minerals (Single Nutrients) (CRADAGAB), Vitamin- & Mineral-Fortified Beverage Production (AFAFAFAC)
Keywords
Where Sudeep Pharma is headquartered
LocationHeadquarters
- HQ city
- Vadodara
- HQ country
- India
- HQ region
- Asia
Offices8 records
Markets served
Sudeep Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Infrastructure, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Pharmaceutical Excipients Sales: Sale of mineral-based excipients to pharmaceutical manufacturers for use in tablet formulations, capsules, and other dosage forms. Revenue generated through direct B2B relationships with global pharma companies.
- Food-Grade Minerals Sales: Sale of mineral ingredients for food fortification, including iron, calcium, zinc, and other essential minerals for the food and beverage industry.
- Nutraceutical Ingredients: Sale of specialty ingredients for dietary supplements and nutritional products, including highly bioavailable mineral forms like glycinates.
- Battery Chemicals (New): Entry into battery-grade iron phosphate production for electric vehicles and energy storage systems, with ₹600 crore investment in 100,000 MT plant at Dahej, Gujarat by 2030.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Customized ingredient solutions with pricing based on specifications, volume, and contract terms |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Sudeep Pharma product offering
Product offeringCore offering
Sudeep Pharma manufactures and globally supplies mineral-based pharmaceutical excipients and active ingredients—including calcium phosphates, calcium carbonates, citrates, glycinates, gluconates, iron salts, magnesium, zinc, potassium, and sodium salts—for use in pharmaceutical tablet and capsule formulations, food fortification, and dietary supplements. The company also produces food-grade minerals, encapsulated malic acid, advanced micronutrient premixes (through its NSS subsidiary in Ireland), and battery-grade iron phosphate for EV and energy storage applications, selling exclusively to business customers across 100+ countries.
Product overview
Sudeep Pharma is a leading global manufacturer of mineral-based pharmaceutical excipients and actives serving the Pharmaceutical, Food, and Nutrition industries. The company's product portfolio centers on calcium salts (Calcium Phosphate, Calcium Carbonate) as core offerings, expanded through specialized mineral lines including Iron salts (Ferric Pyrophosphate, Ferrous Fumarate, Ferrous Sulphate), Magnesium, Zinc, Potassium, and Sodium variants. These minerals are produced in multiple chemical forms—Phosphates, Citrates, Glycinates (chelated amino acid complexes), Gluconates, and Carbonates—each optimized for specific bioavailability, solubility, and application requirements. The portfolio spans pharmaceutical excipients, active pharmaceutical ingredients (APIs), and specialty nutrition ingredients. Strategic extensions include Sudeep Nutrition (nutritional specialty ingredients, launched 2021), the May 2025-acquired NSS (advanced micronutrient premixes, HMOs, probiotics from Ireland), and Sudeep Advanced Materials/SAM (green pCAMs for EV batteries, launched 2024). The company serves 100+ countries with operations in India, USA, and Europe, positioning itself from commodity excipients to integrated nutrition solutions including battery chemicals.
Differentiator
Problem solved
Functional benefit
Brands
- Sudeep Nutrition: Nutraceutical and specialty ingredients for food and nutrition industries
- Sudeep Advanced Materials (SAM)
Products and services
- Pharmaceutical Excipients (Calcium Phosphate, Calcium Carbonate)
Quantifiable outcome
- Revenue growth of 27.94% YoY to ₹642.26 crore in FY March 2026
- +4 more outcomes
Companies that use Sudeep Pharma
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
Sudeep Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Sudeep Pharma partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Nutrition Supplies Services (NSS)coreStrategic acquisition of Ireland-based NSS, a European pioneer in advanced micronutrient premixes with 40+ years of experience. NSS specializes in clean-label premixes, HMOs, and probiotic blends meeting EU and WHO standards. The acquisition adds state-of-the-art manufacturing capability and strengthens Sudeep's position in infant formula, medical nutrition, and functional food solutions.
- JRS Pharma (Germany)coreJoint venture partnership from 2015 where Sudeep Pharma and JRS Pharma combined expertise in excipients with Sudeep's manufacturing capabilities. In July 2024, Sudeep Pharma promoters acquired JRS Pharma's 50% stake, regaining 100% ownership of the company.
Scale indicators11 records
Recent moves7 records
Expansion highlights6 records
Sudeep Pharma competitors and assessment
Company assessmentDirect peers
- JRS Pharma: German specialty excipient manufacturer and former 50% JV partner of Sudeep Pharma. Directly competes in binders, fillers, disintegrants, and functional excipients serving global pharmaceutical customers, making it the most directly comparable peer.
- SPI Pharma: Global supplier of functional excipients, antacid actives, and mineral-based drug delivery ingredients. Comparable to Sudeep in serving pharma excipient customers with calcium-based and specialty mineral ingredients.
- Jungbunzlauer: Swiss-based producer of citric acid, gluconates, citrates, and mineral salts used in food, beverage, and pharmaceutical applications. Directly overlaps with Sudeep's citrate, gluconate, and mineral salt product lines.
- Innophos Holdings: North American specialty ingredient producer of phosphate salts and mineral-based ingredients for food, nutrition, and pharmaceutical markets. Closely comparable to Sudeep's phosphate and mineral-based excipient portfolio.
- Gadot Biochemical Industries: Israeli manufacturer of mineral salts including citrates, gluconates, and specialty mineral ingredients for food, beverage, and nutraceutical markets. Direct competitor in the chelate and mineral salt space.
Broad incumbents
- ICL Group: Global specialty minerals and fertilizers company with a specialty food ingredients business. Larger incumbent with overlapping phosphate and mineral ingredient capabilities serving food and pharma markets.
- Tate & Lyle: Global food and beverage ingredient supplier with specialty texturants, fortification ingredients, and mineral-based solutions. Comparable to Sudeep in addressing food and beverage customers with specialty ingredients.
- Kerry Group: Global taste and nutrition company with pharmaceutical excipient and functional ingredient capabilities. Overlaps with Sudeep in nutrition and pharma ingredient categories as a much larger, diversified incumbent.
- Compass Minerals: Producer of specialty mineral products including sulfate of potash and industrial minerals. Comparable as a broader mineral ingredients player, though primarily focused on agriculture and industrial salt rather than pharma.
Regional players
- Pharm-Rx Chemical Corporation: North American distributor and processor of pharmaceutical-grade mineral ingredients including calcium, magnesium, and zinc salts. Comparable supply-chain role to Sudeep's US distribution operations, focused on North American pharma customers.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Sudeep Pharma social profiles
Digital presenceSudeep Pharma compliance and trust
Trust signalCompliance8 records
Sudeep Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sudeep Pharma leadership team
Management profileNumber of profiles
Profiles10 records
Sudeep Pharma subsidiaries and ownership
Company hierarchySubsidiaries4 records
Sudeep Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sudeep Pharma M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sudeep Pharma
What does Sudeep Pharma do?
Sudeep Pharma manufactures and globally supplies mineral-based pharmaceutical excipients and active ingredients—including calcium phosphates, calcium carbonates, citrates, glycinates, gluconates, iron salts, magnesium, zinc, potassium, and sodium salts—for use in pharmaceutical tablet and capsule formulations, food fortification, and dietary supplements. The company also produces food-grade minerals, encapsulated malic acid, advanced micronutrient premixes (through its NSS subsidiary in Ireland), and battery-grade iron phosphate for EV and energy storage applications, selling exclusively to business customers across 100+ countries.
Is Sudeep Pharma a public or private company?
Sudeep Pharma is a public company. It is classified as public and is currently operating.
When was Sudeep Pharma founded?
Sudeep Pharma was founded in 1989. It employs 251 to 500 people.
Where is Sudeep Pharma based?
Sudeep Pharma is headquartered in Vadodara, India, in the Asia region.
How does Sudeep Pharma make money?
Four revenue lines are on record. Pharmaceutical Excipients Sales are the primary driver. The others are food-Grade Minerals Sales, nutraceutical Ingredients and battery Chemicals (New).
Who are Sudeep Pharma's main competitors?
Direct peers on record are JRS Pharma, SPI Pharma, Jungbunzlauer, Innophos Holdings and Gadot Biochemical Industries. Broad incumbents are ICL Group, Tate & Lyle, Kerry Group and Compass Minerals. Pharm-Rx Chemical Corporation is listed as a regional player.
Does Sudeep Pharma have an API?
No public API is recorded for Sudeep Pharma.
What industry is Sudeep Pharma in?
Sudeep Pharma's product category is Pharmaceutical Excipients & Mineral Ingredients. Its primary akta.pro industry code is CRADAOAM, Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes), with a secondary code of AFAJAGAD, Phosphoric Acid & Phosphates (Food-Grade Phosphate Salts). Its NAICS code is 325411 and its SIC code is 2833.